blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3946635

EP3946635 - LOCALLY ACTING TOLL-LIKE RECEPTOR 7 (TLR7) AND/OR TLR8 AGONIST IMMUNOTHERAPY COMPOUNDS AND THEIR USES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.02.2024
Database last updated on 30.10.2024
FormerRequest for examination was made
Status updated on  07.01.2022
FormerThe international publication has been made
Status updated on  09.10.2020
Most recent event   Tooltip16.02.2024Application deemed to be withdrawnpublished on 20.03.2024  [2024/12]
Applicant(s)For all designated states
ALTIMMUNE UK LIMITED
Central Square 5th Floor
29 Wellington Street
Leeds
LS1 4DL / GB
For all designated states
Roberts, Scot
910 Clopper Rd
Suite 201
S Gaitherburg, Maryland 20878 / US
[2022/06]
Inventor(s)01 / GEORGES, Bertrand
Central Square 5th Floor 29 Wellington St
Leeds Yorkshire LS1 4DL / GB
02 / PEGUILLET, Isabelle
910 Clopper Rd Suite 201 S
Gaithersburg, Maryland 20878 / US
03 / ROBERTS, Scot
910 Clopper Rd Sutie 201 S
Gaithersburg, Maryland 20878 / US
[N/P]
Former [2022/06]01 / GEORGES, Bertrand
Leeds Yorkshire LS1 4DL / GB
02 / PEGUILLET, Isabelle
Gaithersburg, Maryland 20878 / US
03 / ROBERTS, Scot
Gaithersburg, Maryland 20878 / US
Representative(s)Bates, Rosica Florence
Brunswick IP Limited
6 Brunswick Cottages
Midsummer Common
Cambridge CB5 8DL / GB
[2022/06]
Application number, filing date20785254.201.04.2020
[2022/06]
WO2020US26213
Priority number, dateUS201962827816P01.04.2019         Original published format: US 201962827816 P
US202062960380P13.01.2020         Original published format: US 202062960380 P
[2022/06]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2020205996
Date:08.10.2020
Language:EN
[2020/41]
Type: A2 Application without search report 
No.:EP3946635
Date:09.02.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 08.10.2020 takes the place of the publication of the European patent application.
[2022/06]
Search report(s)International search report - published on:US12.11.2020
ClassificationIPC:A61K47/64, A61P37/04
[2023/16]
CPC:
A61K47/64 (EP,US); A61K39/0011 (EP,US); A61K39/39 (EP);
A61K9/0019 (EP,US); A61P35/00 (EP); A61P37/04 (EP);
C07D471/04 (EP); A61K2039/585 (EP,US) (-)
Former IPC [2022/06]A61P37/04, A61K31/437, A61K47/64
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/06]
TitleGerman:IMMUNOTHERAPIEVERBINDUNGEN MIT LOKAL WIRKENDEM TOLL-LIKE-REZEPTOR 7 (TLR7) UND/ODER TLR8-AGONIST UND IHRE VERWENDUNGEN[2022/06]
English:LOCALLY ACTING TOLL-LIKE RECEPTOR 7 (TLR7) AND/OR TLR8 AGONIST IMMUNOTHERAPY COMPOUNDS AND THEIR USES[2022/06]
French:COMPOSÉS D'IMMUNOTHÉRAPIE AGONISTES DU RÉCEPTEUR 7 DE TYPE TOLL (TLR7) ET/OU TLR8 À ACTION LOCALE ET LEURS UTILISATIONS[2022/06]
Entry into regional phase02.11.2021National basic fee paid 
02.11.2021Search fee paid 
02.11.2021Designation fee(s) paid 
02.11.2021Examination fee paid 
Examination procedure02.11.2021Examination requested  [2022/06]
30.05.2022Amendment by applicant (claims and/or description)
01.11.2023Application deemed to be withdrawn, date of legal effect  [2024/12]
22.11.2023Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/12]
Fees paidRenewal fee
27.04.2022Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.04.202304   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2012294885  (DAVID SUNIL A [US], et al);
 [A]US2014242108  (LIOUX THIERRY [FR], et al);
 [A]US2016310603  (GEORGES BERTRAND [GB]);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.